Braveheart Bio
BRVE----
全部股東
股東類型
- 創投/私募59.85%
- 公眾及其他16.34%
- 個人與內幕人士14.73%
- 上市公司9.00%
- 機構投資者0.08%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Forbion Capital Partners B.V. | 26.47% | 2,182.60 萬 | 23.46% | +2,157.43 萬 | |
OrbiMed Advisors LLC | 14.77% | 1,217.52 萬 | -- | +1,217.52 萬 | |
Andreessen Horowitz LLC | 12.41% | 1,023.24 萬 | -- | +1,023.24 萬 | |
Travis MurdochCEO, President & Director | 10.11% | 833.36 萬 | 12.44% | +645.00 萬 | |
Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 9.00% | 742.01 萬 | -- | +742.01 萬 | |
Frazier Life Sciences Management, LP | 6.19% | 510.74 萬 | -- | +510.74 萬 | |
Jason ColomaFormer Director | 1.33% | 110.05 萬 | 1.67% | +84.92 萬 | |
David MalekDirector | 1.23% | 101.33 萬 | 1.53% | +78.29 萬 | |
James RickeyChief Financial Officer | 0.85% | 70.36 萬 | 0.99% | +54.93 萬 | |
Christopher ViehbacherIndependent Chairman | 0.74% | 60.95 萬 | 1.11% | +45.51 萬 | |
Michele AndersonChief Development Officer | 0.40% | 33.22 萬 | 0.50% | +25.66 萬 | |
David LubnerIndependent Director | 0.07% | 5.56 萬 | -- | +5.56 萬 | |
Vanguard Capital Management, LLC | 0.06% | 5.26 萬 | -- | +5.26 萬 | 31/08/2026 |
FMR LLC | 0.02% | 1.28 萬 | -- | +1.28 萬 | 30/09/2026 |
Vanguard Portfolio Management, LLC | <0.01% | 1,076.00 | -- | +1,076.00 | 31/08/2026 |